StocksFin Logo
AbCellera Biologics Inc...
AbCellera Biologics Inc. country of incorporation
|
https://www.abcellera.com
|
Dr. Carl L. Hansen
|
475 employees
NASDAQ | Healthcare | Biotechnology
Tilray Brands, Inc.
Tilray Brands, Inc. country of incorporation
|
https://www.tilray.com
|
Mr. Brendan Kennedy
|
1,700 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
Q322 reported Nov 8, 2022 Reporting Period
$101.38M 1740.6% vs. Q321 Revenues Q322
85.17% -14.8% vs. Q321 Gross Profit Margin
26.26% 106.8% vs. Q321 Net Profit Margin
-141.3M ! -2282% vs. Q321 Free Cash Flow Q322
$0.09 212.5% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Q123 reported Oct 7, 2022 Reporting Period
$153.21M -8.8% vs. Q122 Revenues Q123
31.73% 4.6% vs. Q122 Gross Profit Margin
-47.96% ! -93.5% vs. Q122 Net Profit Margin
-49.27M ! 47.2% vs. Q122 Free Cash Flow Q123
$-0.13 ! -62.5% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Ratios
As of
Sep 30, 2022
Nov 30, 2022
Quick Ratio
9.19
1.23
Current Ratio
9.86
1.91
Cash Ratio
3.51
0.45
Price to Book
2.26
0.5
Price to Sales
27.83
15.45
Price to Earnings
26.5
-9.03